Since previous studies on DAT binding in depression have evaluated the differences between patients with depression and healthy controls, it was difficult to determine whether the altered DAT binding in depression reflects the cumulative changes that occur after the onset of depression or a temporary depressive state. Here, SLC6A3 is linked to depressive symptom measurement.